Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Fiscal Year 1999 Competitive Supplemental Funds for Comprehensive STD Prevention Systems: Monitoring Prevalence of STDs and TB Infection in Persons Entering Corrections Facilities.

[Federal Register Volume 64, Number 162 (Monday, August 23, 1999)]
[Notices]
[Page 45971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21769]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Fiscal Year 1999 Competitive Supplemental Funds for 
Comprehensive STD Prevention Systems: Monitoring Prevalence of STDs and 
TB Infection in Persons Entering Corrections Facilities.

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability and Injury Prevention and Control 
Special Emphasis Panel: Fiscal Year 1999 Competitive Supplemental 
Funds for Comprehensive STD Prevention Systems: Monitoring 
Prevalence of STDs and TB Infection in Persons Entering Corrections 
Facilities, Program Announcement # 99000-D.
    Time and Date: 8:30 a.m.-9 a.m., September 2, 1999 (Open); 9 
a.m.-4:30 p.m., September 2, 1999 (Closed).
    Place: National Center for HIV, STD, and TB Prevention, CDC, 
Corporate Square, Building 10, Conference Room 1304, Atlanta, Ga. 
30329.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to P.L. 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement #99000-D. Due to administrative delays this 
notice is published less than 15 days prior to the meeting.
    Contact person for more information: Beth Wolfe, Prevention 
Support Office, National Center for HIV, STD, and TB Prevention, 
CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/
S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail 
eow1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: August 16, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-21769 Filed 8-18-99; 12:52 pm]
BILLING CODE 4163-18-P